Young onset of primary Sjogren's syndrome: clinical and immunological characteristics

被引:80
作者
Ramos-Casals, M
Cervera, R
Font, J
Garcia-Carrasco, M
Espinosa, G
Reino, S
Pallares, L
Ingelmo, M
机构
[1] Univ Barcelona, Hosp Clin, Unitat Malalties Autoinmunes Sistem, Dept Med,IDIBAPS, Barcelona 08036, Catalonia, Spain
[2] Univ Autonoma Puebla, Sch Med, Rheumat Dis Unit, Puebla 72570, Mexico
[3] Hosp Son Dureta, Dept Internal Med, Mallorca, Spain
关键词
primary Sjogren's syndrome; Hodgkin's lymphoma; non-Hodgkin's lymphoma;
D O I
10.1191/096120398678920019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of our study was to determine the clinical and immunological characteristics of primary Sjogren's syndrome (SS) in patients with a young onset of the disease. We included 144 consecutive patients (134 female and 10 male, mean age at onset 53 y; range 20-87 y) visited in our Units. All patients were white and fulfilled four or more of the diagnostic criteria for SS, proposed by the European Community Study Group in 1993. Disease onset was determined on the basis of the appearance of symptoms strongly suggestive of SS. In 13 (9%) patients, disease onset occurred before the age of 35. All were female and the disease onset occurred between 20-34 y (mean, 28 y). When compared with patients with older onset, patients with a young onset of the primary SS presented a higher prevalence of lymphadenopathy (54% vs 6%, P < 0.001), rheumatoid factor (70% vs 39%, P = 0.034), anti-Ro/SS-A antibodies (70% vs 28%, P = 0.004) and monoclonal immunoglobulins (23% vs 4%, P = 0.02) in their sera. From the initial diagnosis of SS, three patients with a young-onset of the primary SS have developed lymphoproliferative disease at the time of the study, compared with one patient of the older-onset group (23% vs 1%, P = 0.002). Our study shows several differences between younger and older onset patients, including a higher incidence of lymphomas in the younger, thus confering to the age at onset of the disease a prognostic value.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 34 条
[1]  
ANAYA JM, 1995, J RHEUMATOL, V22, P1152
[2]   Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome [J].
Anaya, JM ;
McGuff, HS ;
Banks, PM ;
Talal, N .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1996, 25 (05) :337-346
[3]  
ANAYA JM, 1994, REV ESP REUMATOL, V21, P337
[4]   SALIVARY-GLAND IMMUNOGLOBULIN AND RHEUMATOID-FACTOR SYNTHESIS IN SJOGRENS SYNDROME - NATURAL-HISTORY AND RESPONSE TO TREATMENT [J].
ANDERSON, LG ;
ASOFSKY, R ;
HYLTON, MB ;
SCHALL, GL ;
TOMASI, TB ;
TALAL, N ;
TARPLEY, TM ;
WOLF, RO ;
CUMMINGS, NA .
AMERICAN JOURNAL OF MEDICINE, 1972, 53 (04) :456-&
[5]   LATE ONSET SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BAKER, SB ;
ROVIRA, JR ;
CAMPION, EW ;
MILLS, JA .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (05) :727-732
[6]  
BELL DA, 1988, J RHEUMATOL, V15, P723
[7]  
CATOGGIO LJ, 1984, J RHEUMATOL, V11, P175
[8]   Subgroups of primary Sjogren's syndrome. Sjogren's syndrome in male and paediatric Greek patients [J].
Drosos, AA ;
Tsiakou, EK ;
Tsifetaki, N ;
Politi, EN ;
SiamopoulouMavridou, A .
ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) :333-335
[9]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN ELDERLY [J].
FOAD, BSI ;
SHEON, RP ;
KIRSNER, AB .
ARCHIVES OF INTERNAL MEDICINE, 1972, 130 (05) :743-+
[10]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN THE ELDERLY - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS [J].
FONT, J ;
PALLARES, L ;
CERVERA, R ;
LOPEZSOTO, A ;
NAVARRO, M ;
BOSCH, X ;
INGELMO, M .
ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 (10) :702-705